Literature DB >> 3944091

Novel blood group H glycolipid antigens exclusively expressed in blood group A and AB erythrocytes (type 3 chain H). I. Isolation and chemical characterization.

H Clausen, S B Levery, R Kannagi, S Hakomori.   

Abstract

A series of blood group H antigens reacting with monoclonal antibody MBrl has been found in human blood group A and AB erythrocytes, but not in O or B erythrocytes. These H antigens are clearly different from the globo-H structure (Fuc alpha 1----2Gal beta 1----3GalNAc beta 1----3Gal alpha 1----4Gal beta 1----4Glc beta 1----1Cer), which was previously isolated from O erythrocytes and is also reactive with the MBrl antibody. The new series of H antigens associated with blood group A has been characterized as having TLC mobilities which approximately coincide with those of H2, H3, and H4 glycolipids. One of these A-associated H antigens, having a similar TLC mobility as the H2 glycolipid, was isolated from A erythrocytes and was characterized by 1H NMR spectroscopy, methylation analysis, and enzymatic degradation as having the structure shown below: (formula, see text). The structure represents a precursor of the repetitive A epitope attached to type 2 chain, previously called type 3 chain A (Clausen, H., Levery, S. B., Nudelman, E., Tsuchiya, S., and Hakomori, S. (1985) Proc. Natl. Acad. Sci. U.S.A. 82, 1199-1203). This A-associated H structure is hereby called type 3 chain H.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3944091

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens.

Authors:  Anne M Hutson; Robert L Atmar; Donald M Marcus; Mary K Estes
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Evaluation of group A1B erythrocytes converted to type as group O: studies of markers of function and compatibility.

Authors:  Hong-Wei Gao; Hai-Long Zhuo; Xue Zhang; Shou-Ping Ji; Ying-Xia Tan; Su-Bo Li; Yan-Jun Jia; Hua Xu; Qing-Fa Wu; Zhi-Min Yun; Qun Luo; Feng Gong
Journal:  Blood Transfus       Date:  2015-09-02       Impact factor: 3.443

3.  Expression of H type 1 antigen of ABO histo-blood group in normal colon and aberrant expressions of H type 2 and H type 3/4 antigens in colon cancer.

Authors:  N Fujitani; Y Liu; S Toda; K Shirouzu; T Okamura; H Kimura
Journal:  Glycoconj J       Date:  2000-05       Impact factor: 2.916

4.  Expression of A and H blood-group and of CD44 antigens during chemical rat colonic carcinogenesis.

Authors:  F Hallouin; C Goupille; M le Cabellec; J Bara; J le Pendu
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

5.  Altered expression of sialylated carbohydrate antigens in HT29 colonic carcinoma cells.

Authors:  D R Mack; P W Cheng; F Perini; S Wei; M A Hollingsworth
Journal:  Glycoconj J       Date:  1998-12       Impact factor: 2.916

6.  Aberrant expression of histo-blood group A type 3 antigens in vascular endothelial cells in inflammatory sites.

Authors:  Mizuho Nosaka; Yuko Ishida; Aki Tanaka; Takahito Hayashi; Tomoko Miyashita; Chikako Kaminaka; Wolfgang Eisenmenger; Fukumi Furukawa; Akihiko Kimura
Journal:  J Histochem Cytochem       Date:  2007-11-12       Impact factor: 2.479

7.  Norwalk virus-like particles bind specifically to A, H and difucosylated Lewis but not to B histo-blood group active glycosphingolipids.

Authors:  Jonas Nilsson; Gustaf E Rydell; Jacques Le Pendu; Göran Larson
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

8.  Structural characterization of blood group A glycosphingolipids recognized by the antibody 3G9-A.

Authors:  J B Briggs; R Mandrell; B A Macher
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

9.  Topography of the combining region of a Thomsen-Friedenreich-antigen-specific lectin jacalin (Artocarpus integrifolia agglutinin). A thermodynamic and circular-dichroism spectroscopic study.

Authors:  S K Mahanta; M V Sastry; A Surolia
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.